PHATHOM PHARMACEUTICAL

Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates

11 مايو 2021 08:00:04 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

06 مايو 2021 17:48:26 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints

29 أبريل 2021 16:01:00 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

06 أبريل 2021 08:00:02 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress

30 مارس 2021 16:05:01 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial

19 يناير 2021 08:30:00 بحسب Nasdaq GlobeNewswire